Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Juan Ignacio Esteban Mur

Juan Ignacio Esteban Mur

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Juan Ignacio Esteban Mur

Juan Ignacio Esteban Mur

Juan Ignacio Esteban Mur

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Borja González Rodríguez

Borja González Rodríguez

Reconstructive Surgery of the Locomotor System
Read more
Joana Rita Marques Soares

Joana Rita Marques Soares

Predoctoral researcher
Systemic Diseases
Read more
Maria Pilar Redondo Gonzalez

Maria Pilar Redondo Gonzalez

Research assistant
Microbiology
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.